These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10699539)

  • 61. [Diarrhea caused by systemic anti-cancer treatments].
    Dischl-Antonioni I; Berthod G; Hiroz P; Anchisi S
    Rev Med Suisse; 2016 Sep; 12(529):1462-1467. PubMed ID: 28675266
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mechanisms of TKI-induced diarrhea in cancer patients.
    Bowen JM
    Curr Opin Support Palliat Care; 2013 Jun; 7(2):162-7. PubMed ID: 23399616
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of octreotide in post chemotherapy and/or radiotherapy diarrhea: prophylaxis or therapy?
    Sun JX; Yang N
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e108-13. PubMed ID: 23297685
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma.
    Petrelli NJ; Rodriguez-Bigas M; Rustum Y; Herrera L; Creaven P
    Cancer; 1993 Sep; 72(5):1543-6. PubMed ID: 8348489
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines.
    Liu D; Yan C; Xu L; Wang Y; Han W; Zhang X; Liu K; Huang X
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1567-75. PubMed ID: 20546909
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of Diversion Ileostomy on the Occurrence and Consequences of Chemotherapy-Induced Diarrhea.
    Robertson JP; Wells CI; Vather R; Bissett IP
    Dis Colon Rectum; 2016 Mar; 59(3):194-200. PubMed ID: 26855393
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Graft-versus-host disease: a dermatologic view of an interdisciplinary problem].
    Rupec RA; Plewig G
    J Dtsch Dermatol Ges; 2004 Apr; 2(4):249-59. PubMed ID: 16285321
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Early administration of infliximab for severe ipilimumab-related diarrhea in a critically ill patient.
    Merrill SP; Reynolds P; Kalra A; Biehl J; Vandivier RW; Mueller SW
    Ann Pharmacother; 2014 Jun; 48(6):806-10. PubMed ID: 24651165
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeted therapy-induced diarrhea: A review of the literature.
    Pessi MA; Zilembo N; Haspinger ER; Molino L; Di Cosimo S; Garassino M; Ripamonti CI
    Crit Rev Oncol Hematol; 2014 May; 90(2):165-79. PubMed ID: 24373918
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 1994 Consensus Conference on Acute GVHD Grading.
    Przepiorka D; Weisdorf D; Martin P; Klingemann HG; Beatty P; Hows J; Thomas ED
    Bone Marrow Transplant; 1995 Jun; 15(6):825-8. PubMed ID: 7581076
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
    Topkan E; Karaoglu A
    Oncology; 2006; 71(5-6):354-60. PubMed ID: 17873499
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diarrhea in Multiple Myeloma: A Review of the Literature.
    Faiman B
    Clin J Oncol Nurs; 2016 Aug; 20(4):E100-5. PubMed ID: 27441522
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gastrointestinal toxicity or irinotecan.
    Hecht JR
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):72-8. PubMed ID: 9726096
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemotherapy-induced diarrhoea.
    Gibson RJ; Stringer AM
    Curr Opin Support Palliat Care; 2009 Mar; 3(1):31-5. PubMed ID: 19365159
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nuclear Receptor and Stress Response Pathways Associated with Antineoplastic Agent-Induced Diarrhea.
    Okunaka M; Kano D; Uesawa Y
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293277
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Octreotide in the treatment of refractory diarrhea.
    Fried M
    Digestion; 1999; 60 Suppl 2():42-6. PubMed ID: 10207230
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cancer-related diarrhea: selected findings of a national survey of oncology nurse experiences.
    Rutledge DN; Engelking C
    Oncol Nurs Forum; 1998 Jun; 25(5):861-73. PubMed ID: 9644702
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment.
    Stringer AM; Gibson RJ; Bowen JM; Logan RM; Yeoh AS; Keefe DM
    J Support Oncol; 2007 Jun; 5(6):259-67. PubMed ID: 17624050
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of chemotherapy on gastrointestinal functions and the enteric nervous system.
    Escalante J; McQuade RM; Stojanovska V; Nurgali K
    Maturitas; 2017 Nov; 105():23-29. PubMed ID: 28545907
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical implications of chemotherapy-induced diarrhea in patients with cancer.
    Arnold RJ; Gabrail N; Raut M; Kim R; Sung JC; Zhou Y
    J Support Oncol; 2005; 3(3):227-32. PubMed ID: 15915825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.